Design and screening of syringic acid analogues as BAX activators-An in silico approach to discover "BH3 mimetics". - Srinivasulu Cheemanapalli; Anuradha C. M.; Suresh Babu Pakala; Suresh Kumar Chitta (Comput. Biol. Chem., 2018)

A new insight into identification of in silico analysis of natural compounds targeting GPR120. - Nagaraju Chinthakunta; Srinivasulu Cheemanapalli; Surekha Chinthakunta; Anuradha C. M.; Suresh Kumar Chitta (Netw. Model. Anal. Health Informatics Bioinform., 2018)

Comparative binding studies of curcumin and tangeretin on up-stream elements of NF-kB cascade: a combined molecular docking approach. - Srinivasulu Cheemanapalli; Nagaraju Chinthakunta; Nagoor Meeravali Shaikh; Vutharadhi Shivaranjani; Ramachandra Reddy Pamuru; Suresh Kumar Chitta (Netw. Model. Anal. Health Informatics Bioinform., 2019)

In vitro and in silico perspectives to explain anticancer activity of a novel syringic acid analog ((4-(1H-1, 3-benzodiazol-2-yl)-2, 6-dimethoxy phenol)) through apoptosis activation and NFkB inhibition in K562 leukemia cells. - Srinivasulu Cheemanapalli; Chandrasekaran Palaniappan; Yeshwanth Mahesh; Yuvaraj Iyyappan; Suresh Yarrappagaari; Kanagaraj Sekar (Comput. Biol. Medicine, 2023)

Transcriptomic analysis of human castration-resistant prostate cancer: Insights into novel therapeutic strategies. - Ramanjaneyulu Golla; Sneha Jaiswal; Anaswara Jayan; Srinivasulu Cheemanapalli (Comput. Biol. Chem., 2025)